Literature DB >> 30093414

Tobacco company strategies to identify and promote the benefits of nicotine.

Pamela M Ling1, Stanton A Glantz2.   

Abstract

BACKGROUND: In response to a changing regulatory and consumer landscape, tobacco companies developed new strategies to promote cigarettes and smoking. We examined one of these strategies: to fund and conduct scientific research related to potential benefits of nicotine, and to use their findings to promote nicotine.
METHODS: Qualitative analysis of previously secret tobacco industry documents from the Truth (formerly Legacy) Tobacco Documents Library (industrydocuments.library.ucsf.edu/tobacco), triangulated with data from other sources, including the online search engine Google, from the 1970s to December 2017.
RESULTS: After publication of the 1988 Surgeon General's report on nicotine addiction, tobacco companies (particularly RJ Reynolds) intensified efforts to promote the benefits of nicotine while downplaying its addictiveness and health risks. Activities included building relationships with academic institutions and funding scientific studies of the benefits of nicotine on cognition and other performance areas through intramural and extramural programmes. Companies then promoted their research findings through public relations campaigns, often minimising nicotine's health risks by comparing it to caffeine or coffee. These comparisons appeared in highly publicised scientific meetings and interviews with the press. Nicotine-positive messages reappeared in the popular press and on some company websites in the 2010s.
CONCLUSIONS: Tobacco companies implemented strategies to promote benefits of nicotine to scientific and general audiences while minimising its health risks. These strategies reappeared at the time novel tobacco products like electronic cigarettes were introduced. A greater awareness of the source of claims related to purported benefits of nicotine could inform discussions about emerging tobacco products. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  nicotine; tobacco industry; tobacco industry documents

Mesh:

Substances:

Year:  2018        PMID: 30093414      PMCID: PMC6368903          DOI: 10.1136/tobaccocontrol-2018-054300

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  29 in total

1.  A double blind study of the effects of smoking on heart rate: is there tachyphylaxis?

Authors:  M E Houlihan; W S Pritchard; J H Robinson
Journal:  Psychopharmacology (Berl)       Date:  1999-05       Impact factor: 4.530

2.  Tobacco industry documents: treasure trove or quagmire?

Authors:  R E Malone; E D Balbach
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

3.  Nicotine evokes cell death in embryonic rat brain during neurulation.

Authors:  T S Roy; J E Andrews; F J Seidler; T A Slotkin
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

4.  Psychophysiological and subjective effects of cigarettes having varying nicotine yields but relatively constant "tar' yields.

Authors:  W S Pritchard; J H Robinson; T D Guy; R A Davis; M F Stiles
Journal:  Neuropsychobiology       Date:  1996       Impact factor: 2.328

5.  EEG effects of smoking: Is there tachyphylaxis?

Authors:  M Houlihan; W Pritchard; J Robinson
Journal:  Neuropsychobiology       Date:  2001       Impact factor: 2.328

6.  Tobacco industry sociological programs to influence public beliefs about smoking.

Authors:  Anne Landman; Daniel K Cortese; Stanton Glantz
Journal:  Soc Sci Med       Date:  2008-02       Impact factor: 4.634

7.  Fetal nicotine or cocaine exposure: which one is worse?

Authors:  T A Slotkin
Journal:  J Pharmacol Exp Ther       Date:  1998-06       Impact factor: 4.030

8.  Deficits in development of central cholinergic pathways caused by fetal nicotine exposure: differential effects on choline acetyltransferase activity and [3H]hemicholinium-3 binding.

Authors:  E A Zahalka; F J Seidler; S E Lappi; E C McCook; J Yanai; T A Slotkin
Journal:  Neurotoxicol Teratol       Date:  1992 Nov-Dec       Impact factor: 3.763

9.  Nicotine and addiction. The Brown and Williamson documents.

Authors:  J Slade; L A Bero; P Hanauer; D E Barnes; S A Glantz
Journal:  JAMA       Date:  1995-07-19       Impact factor: 56.272

Review 10.  Tobacco documents research methodology.

Authors:  Stacey J Anderson; Phyra M McCandless; Kim Klausner; Rachel Taketa; Valerie B Yerger
Journal:  Tob Control       Date:  2011-05       Impact factor: 6.953

View more
  2 in total

1.  In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign.

Authors:  Cristin E Kearns; Stanton A Glantz; Dorie E Apollonio
Journal:  BMC Public Health       Date:  2019-08-22       Impact factor: 3.295

Review 2.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.